Key Financials Snapshot

TTM · Consolidated · ₹ in Cr
Market Cap
-
Stock P/E
—
P/B
—
Current Price
₹10.4
Book Value
₹ 0
Face Value
10
52W High
—
52W Low
—
Dividend Yield
—

Maestros MedilineSys Share Price

Live · BSE · Inception: 1972
₹ | |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Consolidated · annual

Maestros MedilineSys Quarterly Results

#(Fig in Cr.) Dec 2011 Mar 2012 Jun 2012 Sep 2012 Dec 2012 Mar 2013 Jun 2013 Sep 2013 Dec 2013 Sep 2014
Net Sales 8 14 8 8 5 3 3 2 0 1
Other Income 0 -0 0 0 0 0 0 0 0 0
Total Income 8 14 8 8 5 3 3 2 0 1
Total Expenditure 7 11 7 8 6 9 4 0 0 2
Operating Profit 1 3 1 -0 -1 -5 -1 2 -0 -1
Interest 0 3 0 0 1 2 0 0 0 0
Depreciation 0 1 0 0 0 1 0 1 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 0 -1 -2 -8 -2 1 -1 -1
Provision for Tax 0 -0 0 0 0 -0 0 0 0 0
Profit After Tax 0 -0 0 -1 -2 -8 -2 1 -1 -1
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 0 -0 0 -1 -2 -8 -2 1 -1 -1
Adjusted Earnings Per Share 0.9 -0.2 0.1 -2.5 -5.6 -17.8 -3.7 3.2 -1.3 -2

Maestros MedilineSys Profit & Loss

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 TTM
Net Sales 42 42 22 7 4 1 6
Other Income 1 0 1 0 0 0 0
Total Income 43 43 23 7 4 1 6
Total Expenditure 33 35 32 20 26 3 6
Operating Profit 9 8 -9 -13 -21 -2 0
Interest 3 4 5 1 0 0 0
Depreciation 2 2 2 1 1 1 1
Exceptional Income / Expenses 0 0 0 -1 0 0 0
Profit Before Tax 4 2 -17 -16 -22 -3 -3
Provision for Tax 0 -0 -1 -0 0 0 0
Profit After Tax 4 2 -16 -16 -22 -3 -3
Adjustments 0 0 0 0 0 0 0
Profit After Adjustments 4 2 -16 -16 -22 -3 -3
Adjusted Earnings Per Share 8.4 4.8 -35.7 -35.9 -51 -6.9 -3.8

Maestros MedilineSys Balance Sheet

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Shareholder's Funds 39 18 2 -14 -37 -40
Minority's Interest 0 0 0 0 0 0
Borrowings 4 24 30 30 30 30
Other Non-Current Liabilities 4 1 1 1 2 2
Total Current Liabilities 29 36 41 40 29 31
Total Liabilities 75 78 74 57 23 22
Fixed Assets 31 16 15 13 12 11
Other Non-Current Assets 1 8 2 2 3 3
Total Current Assets 44 55 57 42 9 9
Total Assets 75 78 74 57 23 22

Maestros MedilineSys Cash Flow

#(Fig in Cr.) Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Opening Cash & Cash Equivalents 6 2 4 0 0 0
Cash Flow from Operating Activities 3 -8 -7 -0 -0 0
Cash Flow from Investing Activities -6 -15 1 1 -0 0
Cash Flow from Financing Activities 1 24 2 -0 -0 0
Net Cash Inflow / Outflow -2 1 -4 0 -1 0
Closing Cash & Cash Equivalent 4 4 0 0 -0 0

Maestros MedilineSys Ratios

# Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016
Earnings Per Share (Rs) 8.39 4.75 -35.69 -35.87 -50.96 -6.87
CEPS(Rs) 13.82 9.01 -30.98 -33.6 -49.17 -5.27
DPS(Rs) 0 0 0 0 0 0
Book NAV/Share(Rs) 89.94 40.08 4.14 -32.05 -84.8 -91.66
Core EBITDA Margin(%) 19.49 17.94 -46.08 -187.89 -505.06 -384
EBIT Margin(%) 15.82 14.09 -51.99 -211.63 -522.46 -473.52
Pre Tax Margin(%) 8.9 4.57 -76.38 -219.27 -523.21 -477.29
PAT Margin (%) 8.62 4.9 -70.72 -219.27 -523.21 -477.29
Cash Profit Margin (%) 14.2 9.28 -61.38 -205.35 -504.76 -366.22
ROA(%) 5.08 2.71 -20.59 -23.93 -55.63 -13.23
ROE(%) 9.81 7.31 -161.46 0 0 0
ROCE(%) 14.32 11.12 -21.25 -34.2 -82.33 -19.04
Receivable days 116.1 169.56 399.4 1236.2 1184.71 1311.03
Inventory Days 101.56 119.3 220.77 373.9 126.55 208.71
Payable days 159.14 181.86 202.85 255.72 389.23 1267.77
PER(x) 6.44 5.66 0 0 0 0
Price/Book(x) 0.6 0.67 6.89 -0.31 -0.12 0
Dividend Yield(%) 0 0 0 0 0 0
EV/Net Sales(x) 0.75 1.11 2.81 7.71 13.76 104.18
EV/Core EBITDA(x) 3.42 5.98 -6.49 -4.08 -2.71 -25.44
Net Sales Growth(%) 39.07 1.46 -48.68 -67.71 -39.82 -86.82
EBIT Growth(%) 112.55 -11.21 -291.91 -31.95 -46.98 86.61
PAT Growth(%) 514.13 -43.36 -850.89 -0.51 -42.06 86.52
EPS Growth(%) 514.13 -43.36 -850.88 -0.51 -42.06 86.52
Debt/Equity(x) 0.3 2.22 27.47 -3.64 -1.46 -1.36
Current Ratio(x) 1.51 1.53 1.39 1.05 0.3 0.28
Quick Ratio(x) 1.05 1.12 1.09 0.99 0.28 0.28
Interest Cover(x) 2.29 1.48 -2.13 -27.69 -692.68 -125.4
Total Debt/Mcap(x) 0.5 3.31 3.99 11.7 11.85 0

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -75% -64% -53% —
Operating Profit CAGR — — 0% —
PAT CAGR — — 0% —
Share Price CAGR — — — 0%
ROE Average 0% 0% -31% -24%
ROCE Average -19% -45% -29% -22%

Maestros MedilineSys Shareholding Pattern

Latest · Sep 2016
100% held
Promoters 49.64 %
FII 0 %
DII (MF + Insurance) 1.49 %
Public (retail) 48.87 %
# Sep 2013 Dec 2013 Mar 2014 Jun 2014 Sep 2014 Dec 2014 Dec 2015 Mar 2016 Jun 2016 Sep 2016
Promoter 48.8548.8548.8548.8549.6449.6449.6449.6449.6449.64
FII 0000000000
DII 6.951.491.491.491.491.491.491.491.491.49
Public 44.2149.6649.6649.6648.8748.8748.8748.8748.8748.87
Others 0000000000
Total 100100100100100100100100100100

Maestros MedilineSys Peer Comparison

Medical Equipment/Supplies/Accessories Edit Columns

Maestros MedilineSys Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

Maestros MedilineSys Pros & Cons

Pros

Cons

  • Promoter holding is low: 49.64%.
  • Company has a low return on equity of 0% over the last 3 years.
  • Debtor days have increased from 389.23 to 1267.77days.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp